Search

EHA-funded study in The Lancet Haematology: Economic Burden of Blood Disorders in EU is €23 billion

In Europe blood disorders affect around 80 million people. The total cost of blood disorders consists of healthcare expenditure (€15. 6 billion), productivity loss due to illness and mortality (€5. 6 billion), and the costs of informal care (€1.

Read more

Novel basis for chemoresistance in AML: DNMT3A R882 mutations promote chemoresistance and residual disease through impaired DNA damage sensing

Although most acute myeloid leukemia (AML) patients initially respond to chemotherapy, the majority subsequently relapses and succumbs to refractory disease. Residual leukemic cells that survived chemotherapy may persist over time and later cause the disease to come back.

Read more

Chairs and Members

Chair (2022–2024 term)Edward Laane

Co-chairs (2022–2024 term)
Esther Natalie Oliva
Sam Salek
Secretary (2022–2024 term)Tatyana Ionova

SWG Executive Board members (2022–2024 term)
Tatiana Ionova, Сhair of Department, St. Petersburg State University Hospital, St.

Read more

ATMPs and CAR-T: the uptake challenge

Advanced therapy medicinal products (ATMPs) are a game changer for improving the life of patients with severe to life-threatening diseases. In hematology, for instance, CAR T cell therapy has shown promising results in tackling different blood cancers.

Read more

EHA joins ESMO in calling for EU action on shortages of essential medicines

EHA joins ESMO in calling for EU action on shortages of essential medicines

The European Hematology Association (EHA) has endorsed and signed a collective Call to Action, prepared by the European Society for Medical Oncology (ESMO), on shortages of inexpensive, essential…

Read more

HARMONY: Big data for better and faster treatment

HARMONY Alliance: A European Network of Excellence for Big Data in Hematology - Enabling Better and Faster Treatment based on Big Data technologies
Despite data being a key driver for modern evidence-based medicine, we have been struggling with the same challenge for…

Read more

1st EHA-Balkan Hematology Day

EHA is joining forces with the national societies from the Balkan countries and co-organizing with them the 1st edition of the EHA-Balkan Hematology Day.

Read more

EU health policy: limited scope, high ambition

Over the past decades, the European Union (EU) has become more involved in public health policy. A recent study showed that a majority of policymakers even identifies EU health policy as a priority for 2020-20241.

Read more

2013 & before

2013
EHA-SWG Scientific Meeting on Thrombocytopenia and Disorders of Platelet Function
September 27-29, 2013 | Lisbon, Portugal

EHA-ROHS-RSH Tutorial on Bone Marrow Transplantation
July 5-7, 2013 | Saint Petersburg, Russia

EHA Tutorial on Lymphoma
May 24-26, 2013 | Cape Town, South Africa

EHA-TSH Tutorial on Chronic Myeloproliferative…

Read more